SNA
68
-2
CCI
31
3
PSX
47
2
MRK
25
-2
GPC
40
3
STZ
54
-3
GE
67
2
SLB
55
2
PFG
45
3
CMG
72
5
CHRW
56
-3
WFC
79
4
NOC
43
11
DNB
82
4
INTC
33
-2
NAVI
52
5
CTSH
56
2
EQIX
64
2
HON
67
2
EQT
57
-2
SNA
68
-2
CCI
31
3
PSX
47
2
MRK
25
-2
GPC
40
3
STZ
54
-3
GE
67
2
SLB
55
2
PFG
45
3
CMG
72
5
CHRW
56
-3
WFC
79
4
NOC
43
11
DNB
82
4
INTC
33
-2
NAVI
52
5
CTSH
56
2
EQIX
64
2
HON
67
2
EQT
57
-2
Financhill
Back

Alaunos Therapeutics 10K Form

Sell
33

TCRT
Alaunos Therapeutics

Last Price:
2.36
Seasonality Move:
11.91%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TCRT News And Ratings

See the #1 stock for the next 7 days that we like better than TCRT

TCRT Financial Statistics

Sales & Book Value

Annual Sales: $5K
Cash Flow: $-781K
Price / Cash Flow: 0
Annual Sales: $1.70
Price / Book: 1.41

Profitability

EPS (TTM): -7.40800
Net Income (TTM): $-11.78M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Alaunos Therapeutics Earnings Forecast

Key Alaunos Therapeutics Financial Ratios

  • The Selling, General & Administrative Expenses for TCRT have been equal to 244,380.00% of Gross Profit Margin.
  • The Research & Development expenses have been 325,580.00% of Revenue.
  • The Interest Expense is -5.47% of Operating Income.
  • The Net Earning history of TCRT is -702,800.00% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 13 years.

Alaunos Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: TCRT
Website: alaunos.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TCRT Technical Analysis vs Fundamental Analysis

Sell
33
Alaunos Therapeutics (TCRT) is a Sell

Is Alaunos Therapeutics a Buy or a Sell?